Skip to main content

Table 2 Economic burden of NCDs in Iran in IRR trillions, 2018

From: Prevention and control of non-communicable diseases in iran: the case for Investment

Cost CVD Cancer Diabetes Respiratory diseases Total
Direct costs
 Total healthcare expenditures 174.54 87.27 52.05 75.45 389.31
Indirect costs
 Cost of absenteeism 18.3 - 2.986 - 23.86
 Cost of presenteeism 104.7 - 73.726 - 181
 Cost of premature death 137.41 101.55 1.936 8.55 244.32
Total indirect costs 260.41 101.55 77.016 8.55 449.18
Total costs
Total costs 434.95 188.82 130.7 84 838.49